Moreover, and in agreement with our results, accumulating evidence indicates the importance of TIMP activities in the fibrosis progression of several pathological conditions (Kim et al. 2005), reporting increased TIMP-1 levels in IPF patients (Todd et al. 2020). This evidence concerns the gene TIMP1 and idiopathic pulmonary fibrosis.